Description
Saphris is an atypical antipsychotic medication used to treat schizophrenia in adults and bipolar I disorder in adults and pediatric patients ages 10-17 years.
The generic name for Saphris is Asenapine.
Fact Table |
Formula |
C17H16ClNO |
License |
EU EMA, US DailyMed, US FDA |
Bioavailability |
35% |
Legal status |
Rx-Only |
Chemical Name |
Asenapine |
Elimination half-life |
24 hours |
Dosage (Strength) |
5mg Sublingual, 10mg Sublingual, 10mg (Tablets) |
Pregnancy |
Consult Doctor |
Brands |
Saphris |
Protein binding |
95% |
PubChem CID |
163091 |
MedlinePlus |
a610015 |
ChEBI |
71253 |
ATC code |
N05AH05 |
DrugBank |
DB06216 |
KEGG |
D11769 |
Routes of administration |
Sublingual, by mouth |
Directions
Once you are prescribed and buy Saphris medication (asenapine) or Saphris generic, it is a sublingual tablet that should be placed under the tongue to dissolve. You should not eat or drink for 10 minutes after taking the medication.
Saphris (asenapine) sublingual tablets come in 2.5 mg, 5 mg, and 10 mg strengths.
The dosage for schizophrenia ranges from 5 mg sublingually twice a day to 10 mg sublingually twice a day.
The dosage for bipolar I disorder in adults ranges from 5 mg sublingually twice a day to 10 mg sublingually twice a day.
The dosage for bipolar I disorder in pediatric patients who are 10 to 17 years old ranges from 2.5 mg sublingually twice a day to 10 mg sublingually twice a day.
Ingredients
The active ingredient in Saphris is asenapine, an Atypical antipsychotic.
Contraindications
Do not take Saphris if you have severe liver problems.
Tell your doctor about any allergies you may have. Do not take Saphris if you are allergic to asenapine or any of the other ingredients in Saphris.
Cautions
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
See full prescribing information for complete boxed warnings.
Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. SAPHRIS is not approved for the treatment of patients with dementia-related psychosis.
Saphris (asenapine) may interact with certain medications. Be sure to tell your doctor about any medications you take, including prescription, over-the-counter, vitamins, and herbal supplements.
Saphris (asenapine) may not be right for everyone. Tell your doctor if you:
- Have dementia-related psychosis as your risk of cerebrovascular events such as stroke or heart disease is increased with the use of Saphris.
- Have diabetes or dyslipidemia. You should monitor for changes in blood sugar levels and weight while taking Saphris.
- Experience fever, rigid muscles, confusion, rapid heart rate, or sweating while taking Saphris as these could be signs of neuroleptic malignant syndrome (NMS). If NMS is suspected, stop taking Saphris immediately and seek medical care right away.
- Experience tardive dyskinesia, or uncontrollable movements of the face, neck, or tongue, Saphris may be stopped if clinically appropriate.
- Have blood pressure problems. You should monitor your heart rate and blood pressure while taking Saphris as it can cause a sudden drop in blood pressure when you stand up from lying down or sitting.
- Have a low white blood cell count (WBC) or have had leukopenia or neutropenia. If your WBC count declines significantly without any other cause, your doctor may discontinue Saphris.
- Have risk factors for QT prolongation.Do not take Saphris with drugs that may also increase the QT interval.
- Have a history of seizures or if you have a condition(s) that increases your risk for seizures.
- Have problems sleeping. Saphris may cause sleepiness or drowsiness. Use caution when driving or operating machinery.
- Are pregnant or plan to become pregnant. Taking Saphris while pregnant may increase the risk of extrapyramidal symptoms and/or symptoms of withdrawal in neonates. Women should be advised of the possible risk to the fetus. Please note that there is a pregnancy exposure registry. This registry monitors the health of mom and baby while taking Saphris during pregnancy.
- Are breastfeeding or plan to start breastfeeding. The effects of Saphris (asenapine) while breastfeeding are unknown. Benefits versus risks must be considered.
Side Effects
Like any medication, Saphris can cause side effects. Tell your doctor if you experience any adverse effects while taking Saphris (asenapine). Saphris (asenapine) side effects that are common include:
- Restlessness, unable to sit still
- Reduced sensation in your mouth
- Sleepiness, drowsiness
- Dizziness
- Extrapyramidal symptoms (problems with movement)
- Altered taste
- Nausea
- Fatigue
- Weight gain
- Increase in appetite
References:
SAPHRIS Prescribing Information. Madison, NJ: Allergan USA, 2021.
Tardive Dyskinesia. National Alliance of Mental Illness. Last updated January 2016.
Accessed November 1, 2021.
About Dr. Savannah Muncy (Page Author)
Dr. Muncy (PharmD) studied science and education as an undergraduate before attending the Appalachian College of Pharmacy where she completed her PharmD in three years. She is currently using her pharmacy and healthcare expertise to write medical content for clients all around the world. She is focused on delivering the most current, accurate, and engaging information to healthcare professionals and patients. Read More....
IMPORTANT NOTE:
The above information is intended to increase awareness of health information and does not suggest treatment or diagnosis. This information is not a substitute for individual medical attention and should not be construed to indicate that use of the drug is safe, appropriate, or effective for you. See your health care professional for medical advice and treatment.
Product Code : 10363